TAF
ALXN

Tredje AP-fonden’s Alexion Pharmaceuticals ALXN Stock Holding History

Tredje AP-fonden’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-25,038
Closed -$4.6M – 278
2021
Q2 		$4.6M Hold
25,038
– – 0.09% 132
2021
Q1 		$3.83M Hold
25,038
– – 0.09% 143
2020
Q4 		$3.91M Hold
25,038
– – 0.1% 141
2020
Q3 		$2.87M Hold
25,038
– – 0.09% 134
2020
Q2 		$2.81M Sell
25,038
-18,288
-42% -$1.94M 0.12% 127
2020
Q1 		$3.89M Buy
43,326
+2,693
+7% +$264K 0.2% 101
2019
Q4 		$4.39M Sell
40,633
-1,972
-5% -$211K 0.22% 116
2019
Q3 		$4.17M Sell
42,605
-3,380
-7% -$381K 0.2% 132
2019
Q2 		$6.02M Buy
45,985
+2,245
+5% +$289K 0.29% 77
2019
Q1 		$5.91M Buy
43,740
+1,512
+4% +$188K 0.31% 77
2018
Q4 		$4.11M Sell
42,228
-29,918
-41% -$3.54M 0.25% 97
2018
Q3 		$10M Sell
72,146
-12,885
-15% -$1.62M 0.48% 48
2018
Q2 		$10.6M Buy
85,031
+11,180
+15% +$1.31M 0.37% 76
2018
Q1 		$8.23M Buy
73,851
+4,600
+7% +$550K 0.29% 87
2017
Q4 		$8.28M Hold
69,251
– – 0.28% 89
2017
Q3 		$9.71M Buy
69,251
+1,075
+2% +$146K 0.34% 75
2017
Q2 		$8.29M Hold
68,176
– – 0.31% 75
2017
Q1 		$8.27M Hold
68,176
– – 0.33% 71
2016
Q4 		$8.34M Sell
68,176
-1,200
-2% -$147K 0.35% 66
2016
Q3 		$8.5M Sell
69,376
-2,711
-4% -$349K 0.38% 62
2016
Q2 		$8.42M Sell
72,087
-2,627
-4% -$373K 0.38% 60
2016
Q1 		$10.4M Buy
74,714
+6,281
+9% +$922K 0.47% 49
2015
Q4 		$13.1M Sell
68,433
-35,805
-34% -$6.25M 0.84% 27
2015
Q3 		$16.3M Buy
104,238
+58,453
+128% +$10.7M 1.59% 11
2015
Q2 		$7.84M Buy
+45,785
New +$7.9M 0.63% 39

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Tredje AP-fonden's ALXN Position: Q3 2021 in Review

Tredje AP-fonden sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 25,038 shares — an estimated $4.6M sold.

Tredje AP-fonden first reported a position in ALXN in Q2 2015 and held it in 25 quarters. The position peaked at $16.3M in Q3 2015. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Tredje AP-fonden reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Tredje AP-fonden sold 25,038 Alexion Pharmaceuticals shares in Q3 2021, an estimated $4.6M.
  • Tredje AP-fonden first reported a position in Alexion Pharmaceuticals in Q2 2015 and held it in 25 quarters.
  • Tredje AP-fonden's Alexion Pharmaceuticals position peaked at $16.3M in Q3 2015.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Tredje AP-fonden's 13F filing for Q3 2021, filed 10 Nov 2021.